DE ROSA, Francesco Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 12.584
EU - Europa 8.912
AS - Asia 3.879
SA - Sud America 691
AF - Africa 189
OC - Oceania 122
Continente sconosciuto - Info sul continente non disponibili 39
Totale 26.416
Nazione #
US - Stati Uniti d'America 12.244
IT - Italia 2.405
CN - Cina 2.041
IE - Irlanda 1.130
SE - Svezia 863
FR - Francia 719
DE - Germania 621
DK - Danimarca 599
UA - Ucraina 452
FI - Finlandia 448
GB - Regno Unito 392
KR - Corea 375
VN - Vietnam 314
ES - Italia 286
PL - Polonia 248
IN - India 208
PE - Perù 199
CA - Canada 189
AT - Austria 171
JP - Giappone 168
TR - Turchia 163
AR - Argentina 122
BR - Brasile 121
MX - Messico 121
CL - Cile 115
AU - Australia 109
BE - Belgio 98
HK - Hong Kong 96
NL - Olanda 88
CO - Colombia 83
GR - Grecia 79
SG - Singapore 75
TH - Thailandia 69
RU - Federazione Russa 66
SA - Arabia Saudita 50
IR - Iran 48
RO - Romania 47
TW - Taiwan 42
ZA - Sudafrica 42
PT - Portogallo 36
PK - Pakistan 34
EG - Egitto 32
CH - Svizzera 30
EU - Europa 28
MY - Malesia 28
MA - Marocco 24
PH - Filippine 23
ID - Indonesia 20
TN - Tunisia 20
UZ - Uzbekistan 20
EC - Ecuador 19
CZ - Repubblica Ceca 18
NG - Nigeria 17
SI - Slovenia 16
BO - Bolivia 15
LB - Libano 15
HU - Ungheria 13
NO - Norvegia 13
NZ - Nuova Zelanda 13
AE - Emirati Arabi Uniti 12
BG - Bulgaria 12
IL - Israele 12
CR - Costa Rica 11
HR - Croazia 11
MU - Mauritius 11
QA - Qatar 11
AP - ???statistics.table.value.countryCode.AP??? 10
KZ - Kazakistan 10
LV - Lettonia 10
BY - Bielorussia 8
ET - Etiopia 8
PS - Palestinian Territory 8
PY - Paraguay 8
UY - Uruguay 8
BA - Bosnia-Erzegovina 7
HN - Honduras 7
GT - Guatemala 6
JO - Giordania 6
RS - Serbia 6
SY - Repubblica araba siriana 6
BD - Bangladesh 5
SN - Senegal 5
DZ - Algeria 4
GH - Ghana 4
IQ - Iraq 4
LK - Sri Lanka 4
MD - Moldavia 4
SK - Slovacchia (Repubblica Slovacca) 4
UG - Uganda 4
CM - Camerun 3
KE - Kenya 3
LT - Lituania 3
LU - Lussemburgo 3
LY - Libia 3
MT - Malta 3
PA - Panama 3
AO - Angola 2
BH - Bahrain 2
LI - Liechtenstein 2
MN - Mongolia 2
Totale 26.395
Città #
Chandler 1.712
Ann Arbor 1.372
Dublin 1.120
Beijing 1.106
Houston 700
Fairfield 693
Torino 459
Villeurbanne 425
Ashburn 405
Princeton 380
Medford 378
Wilmington 345
Nyköping 325
Woodbridge 318
Jacksonville 282
Redwood City 259
Seattle 256
Dearborn 253
Cambridge 216
Warsaw 210
Milan 185
Pisa 170
Lima 152
Vienna 150
Turin 147
Dong Ket 130
Fremont 113
Hangzhou 106
Boston 104
Rome 102
Boardman 89
Guangzhou 79
San Diego 77
Toronto 76
New York 73
Nanjing 72
Brussels 68
Hebei 65
Verona 65
Santiago 61
Shanghai 60
Madrid 55
Norwalk 54
Singapore 46
Seoul 42
Chengdu 40
Washington 40
Falls Church 39
Paris 39
Bologna 37
Istanbul 37
London 36
Central 34
Ankara 32
Barcelona 32
Hefei 31
Tokyo 31
Florence 30
Jinan 30
Bogotá 28
Philadelphia 28
Chicago 27
Naples 27
Athens 26
Buenos Aires 26
Silver Spring 26
Padova 25
Los Angeles 24
Phoenix 24
Fuzhou 23
Kunming 23
Nanchang 23
Sydney 23
Taipei 23
Genoa 22
Guiyang 22
Hanoi 22
Helsinki 22
Riyadh 22
Munich 21
Bangkok 20
Mountain View 20
Ottawa 20
Upper Marlboro 20
Berlin 19
Palermo 19
Pune 19
Columbus 18
Federal 17
Mexico City 17
San Miguel de Tucumán 17
Wuhan 17
Hong Kong 16
Lachine 16
Portland 15
Xian 15
Catania 14
Denver 14
Shenyang 14
Amsterdam 13
Totale 14.890
Nome #
Ceftolozane/tazobactam: place in therapy 1.477
Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review 1.065
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation 848
Intrathecal or intraventricular colistin: a review 415
Antimicrobial prophylaxis in minor and major surgery. 364
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. 330
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 312
Ceftriaxone bone penetration in patients with septic non-union of the tibia 286
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? 275
Re-defining tigecycline therapy 249
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study 249
Anidulafungin for Candida glabrata Infective Endocarditis 239
Health-care Associated KPC-BSI: The Time Has Come. 226
Amikacin dosing in the ICU: we now know more, but still not enough… 223
High rate of respiratory MDR gram-negative bacteria in H1N1-ARDS treated with ECMO. 221
Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma. 211
Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH 204
Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome 200
Repurposed antiviral drugs for COVID-19 — InteriM WHO solidarity trial results 195
Three methods for estimating days of hospitalization because of hospital-acquired infection: a comparison 194
SLC28A2 65C>T predict Sustained Virological Response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1/4. 192
Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1. 174
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation? 171
SLC29A1 −706G>C predict haemoglobin decrease in patients with hepatitis C treated with interferon and ribavirin 170
Antibiotic diffusion in pseudoarthrosic infected bone: glycopeptides, fluoroquinolones and carbapenems 170
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis 170
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. 165
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. 164
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 163
Effect of multidrug-resistant gene polymorphisms on daptomycin concentrations: preliminary results 162
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. 162
Farmacocinetica dell’anidulafungina in pazienti con fibrosi cistica, trapianto epatico e emodiafiltrazione: dati preliminari. 161
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D 159
PHISIOLOGIC VARIABLES AND PHARMCOKINETICS IMIPENEM DURING ENLP. A SINGLE CENTER TRANSPLANTATION EXPERIENCE 154
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS. 151
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection 150
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis 150
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication 149
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients 147
Influenza dei polimorfismi C3453T, C1236T, G2677T/A del gene MDR1 sulle concentrazioni plasmatiche di daptomicina 147
Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection 146
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia 140
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma. 140
Clinical significance of pharmacokinetics of ertapenem in an outpatient setting 139
Farmacocinetica della caspofungina in pazienti sottoposti a trapianto epatico. 136
An unusual calf lesion in an immunocompromised patient. 136
Osteomyelitis caused by Enterobacter cancerogenus infection following a traumatic injury: case report and review of the literature 135
Prophylaxis drug monitoring of itraconazole and voriconazole in the paediatric onco-haematological setting 133
Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. 133
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda. 133
Start Smart with Antimicrobial Stewardship 133
2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections 132
V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis 132
Prophylactic drug monitoring of itraconazole in an oncohematological pediatric patient population. 126
GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Brain Abscesses. Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses. 123
Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study 115
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 113
A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: Beyond the ICU 112
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 112
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 112
Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital. 110
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 110
The effect on mortality of fluconazole or echinocandins treatment in internal medicine wards 108
Infective endocarditis in the real world: the Italian Registry of Infective Endocarditis (Registro Italiano Endocardite Infettiva - RIEI). 108
From ESKAPE to ESCAPE, From KPC to CCC. 107
Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients 106
Management of carbapenem-resistant K. pneumoniae in allogenic stem cell transplant recipients: the Turin bundle 104
Surgical antimicrobial prophylaxis prescribing practices and impact on infection risk: Results from a multicenter surveillance study in Italy (2012-2017) 102
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus 101
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study 101
Wound botulism after traumatic open fracture in Italy 99
Pharmacokinetics of Meropenem in Burn Patients with Infections Caused by Gram Negative Bacteria: Are We Getting Close to the Right Treatment? 99
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 98
First case of E. meningoseptica in Italy in a patient with necrotic hemorrhagic pancreatitis 98
Erratum: A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 patient 97
Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci 94
Neurological disease may precede lymphadenopathies in Actinomyces europaeus infection 93
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 91
Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient 91
Mortality in early- and late-onset candidemia 89
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 89
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge 88
A short course of pegylated interferon-alpha in acute HCV hepatitis 87
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome 86
[Ertapenem. A new carbapenem in a single dose for community acquired infection] 85
Ceftriaxone cerebrospinal fluid levels in adult patients with meningoencephalitis 84
Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study 82
A retrospective study of viral central nervous system infections: relationship amongst aetiology, clinical course and outcome 81
Management of KPC-producing Klebsiella pneumoniae infections 81
Management of H1N1 influenza virus respiratory syndrome 81
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball 80
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 79
Enteropathogenetic nosocomial infections: predisposing clinical characteristics and risk of recurrent infections 79
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots 79
The management of anti-infective agents in intensive care units: the potential role of a ‘fast’ pharmacology 78
Prevention and diagnosis of ventilator-associated pneumonia: a regional survey in Italy 77
Patologie infettive a carico dell'apparato respiratorio 76
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 75
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 74
Acute hepatitis C: dosage and compliance 73
Totale 17.215
Categoria #
all - tutte 72.841
article - articoli 0
book - libri 0
conference - conferenze 4.609
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019898 0 0 0 0 0 0 0 0 0 174 496 228
2019/20203.883 166 115 184 443 345 693 394 280 285 339 307 332
2020/20213.197 306 161 195 194 242 184 195 144 317 354 273 632
2021/20224.867 312 317 325 383 350 392 364 290 259 263 746 866
2022/20236.467 702 464 318 524 584 1.437 445 456 625 223 379 310
2023/20242.779 394 569 198 248 305 342 180 233 108 202 0 0
Totale 27.586